Press "Enter" to skip to content

Psoriasis injection Itolizumab approved for limited use in treating COVID-19: Drug Regulator

India’s drug regulator has approved Itolizumab, used to cure skin ailment psoriasis, for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress, officials said.

Leave your comments

%d bloggers like this: